Medicare Rx “Benefits”: Drug Industry, PBMs Expected To Prosper
Executive Summary
The possibility of a Medicare drug benefit leading to price controls is remote, Uwe Reinhardt, PhD, Princeton University, maintained during a Charles Schwab Capital Markets conference in Washington, D.C. Oct. 29